The cdk-inhibitor p21 CIP1/WAF1 inhibits the activities of cyclin-dependent kinases and proliferating cell nuclear antigen, thereby repressing cell-cycle progression and DNA replication. 
Introduction
Expression of the adenoviral (Ad) 12S and 13S E1A proteins can force quiescent cells to re-enter the cell cycle and can result in the transformation of susceptible mammalian cells. The non-conserved N-terminal domain and the conserved regions CR1 and CR2, which are present in both the 12S and 13S E1A proteins, are important for transformation. Binding of E1A to a number of cellular proteins contributes to this growth-stimulatory effect by altering and, in most instances, inactivating the function of these proteins (reviewed in Moran & Mathews, 1987 ; Peeper & Zantema, 1993 ; Moran, 1994) . Cellular proteins bound to the transforming regions of E1A include tumour-suppressor protein pRb (Whyte et al., 1988) and related proteins p107 (Ewen et al., 1991) and p130 Li et al., 1993) , transcriptional coactivators p300 and CBP (CREB-binding protein) (Arany et al., 1994 (Arany et al., , 1995 Eckner et al., 1994 ; Lundblad et al., 1995) , cyclindependent kinase cdk2 and cyclin A\E (Faha et al., 1993) . The binding of E1A to cellular proteins may be accompanied by Author for correspondence : Alt Zantema.
Fax j31 715276284. e-mail A. Zantema!mcb.MedFac.LeidenUniv.NL changes in gene expression that favour cell-cycle progression. For example, binding of E1A to pRb prevents the formation of repressive pRb\E2F transcription-factor complexes, thereby activating E2F-responsive genes needed for the onset of Sphase (reviewed in Nevins, 1992 ; Moran, 1994) .
Recently, a new class of growth-inhibitory proteins was discovered, the so-called cdk inhibitors. In normal cells, regulation of the activity of cyclin-dependent kinases is crucial for an orderly progression through the cell cycle. Cdk inhibitors can bind to and inhibit the function of cyclin-dependent kinases and thereby negatively affect cell growth (reviewed in Sherr, 1994 ; Hunter & Pines, 1994 ; Nasmyth & Hunt, 1993 ; Peters, 1994 ; Elledge et al., 1996 ; Sherr, 1996) . They can be sub-divided into the CIP\KIP family which inhibit several cyclin-dependent kinases with varying efficiencies : p21 CIP"/WAF" (Harper et al., 1993 ; El-Deiry et al., 1993) , p27 KIP" (Polyak et al., 1994) and p57 KIP# (Lee et al., 1995) , and the INK4-family which inhibit only the activity of the cyclin Dtype-specific cyclin-dependent kinases : p15 INK%B , p16 INK%A (Serrano et al., 1993) , p18 INK%C (Guan et al., 1994) and p19 INK%D (Chan et al., 1995) .
The first cdk inhibitor discovered was p21 CIP"/WAF" . Various groups independently have cloned the same gene, either as an inhibitor of cdk2 activity (Cip1\CAP20) (Gu et al., 1993 ; Harper et al., 1993) , as a transcriptional target of the p53 tumour-suppressor protein (WAF1) (El-Deiry et al., 1993) or as a gene that is induced at senescence (Sdi) (Noda et al., 1994) . Besides binding to cyclin-dependent kinases, p21 CIP"/WAF" can also bind to and inactivate stress-activated kinases (Shim et al., 1996) and casein kinase II (Go$ tz et al., 1996) . This cdk inhibitor can also fulfil other functions, such as inhibition of DNA replication by binding to proliferating cell nuclear antigen (PCNA) (Flores-Rozas et al., 1994 ; Waga et al., 1994 ; Luo et al., 1995) . Evidently, p21 CIP"/WAF" plays a central and diverse role in cell-cycle regulation and thus is an obvious target for viral-transforming proteins, such as the E1A proteins.
It has already been shown that E1A indeed can interfere with induced expression of the p21 CIP"/WAF" gene. The induction of expression of this gene which is observed upon differentiation of keratinocytes can be abrogated by the E1A protein (Missero et al., 1995) . Likewise, no induction of p21 CIP"/WAF" -gene expression was observed after DNA damage or TGF-β treatment in E1A-expressing human cells in contrast to the induction detected in control cells (Datto et al., 1997 ; Steegenga et al., 1996 ; Somasundaram & El-Deiry, 1997) . Furthermore, E1A binds to the p21 CIP"/WAF" -related inhibitor p27 KIP" and inactivates its function upon treatment with TGF-β (Mal et al., 1996) . Apparently, E1A can counteract the induction of active p21 CIP"/WAF" and p27 KIP" by various mechanisms. The inhibitory protein p21 CIP"/WAF" , however, is also a likely target for the E1A proteins upon transformation of susceptible mammalian cells.
In this study, we investigated whether in cells expressing the Ad transforming proteins the levels and\or activities of p21 CIP"/WAF" are influenced in comparison to untransformed cells. Colony-formation assays were performed to determine whether the Ad transforming proteins can counteract the growth-inhibitory functions of p21 CIP"/WAF" . In addition, FACS experiments were performed to determine whether E1A can counteract the function of this inhibitor. We also investigated whether E1A exerts its effect on p21 CIP"/WAF" by binding to it.
Methods
Cell lines, tissue culture, transfections and colony-formation assays. U2OS cells (a human osteosarcoma cell line), normal rat kidney 49F (NRK) cells, primary human embryonic retina (HER) cells, two independent NRK cell lines transformed with the E1 region of Ad5 (NRKXho c2.1 and c2.4) and two independent HER cell lines and one baby rat kidney (BRK) cell line transformed with the same region of Ad5 (HERXho c1, HER-Xho c2 and BRK-Xho c22) were used. These or comparable cell lines have been described previously (Schrier et al., 1979 ; Zantema et al., 1985 ; Dorsman et al., 1995) and all cell lines used express high levels of Ad-E1 proteins. All cells, except for the BRK cells, were grown in Dulbecco's Modified Eagle's Medium (DMEM, Gibco) supplemented with 8 % foetal calf serum and antibiotics. The BRK-Xho c22 cells were maintained in Minimal Essential Medium (MEM, Gibco) supplemented with 8 % newborn calf serum and antibiotics. Insect cells (Spodoptera frugiperda, Sf9) were obtained from the ATCC (CRL 1711) and were grown in TC-100 medium (Gibco) supplemented with 10 % foetal calf serum and antibiotics.
All transfections were performed with the calcium phosphate technique, essentially as described before (van der Eb & Graham, 1980) . For the colony-formation assays, NRK, HER-Xho c1 and BRK-Xho c22 cells were transfected with either 4 µg pCMX-p21 or pCMV-p16 in the presence of 1 µg pCMV-neo. As a control, 5 µg pCMV-neo was transfected alone. After 3 weeks of maintaining the cells in G418-containing medium, G418-resistant colonies were fixed and stained with Coomassie Brilliant Blue according to standard procedures.
Plasmid constructs. The full-length p21 CIP"/WAF" cDNA fragment was isolated from pCEP4-Waf1 (a kind gift from W. S. El-Deiry, University of Pennsylvania School of Medicine, PA, USA) (El-Deiry et al., 1993) and cloned into a CMV-promoter-containing vector (pCMX). Plasmid pCMX-p27 was kindly provided by T. Hunter (Salk Institute, La Jolla, CA, USA) (Toyoshima & Hunter, 1994) and plasmid pCMV-p16 by D. Beach (Cold Spring Harbor Laboratory, NY, USA) (Serrano et al., 1993) . Plasmid pCMV-CD20 was generously provided by R. Bernards (Netherlands Cancer Institute, Amsterdam, The Netherlands). Plasmids pRSV-neo and pRSV-5E1A have been described previously (Offringa et al., 1990) .
Antibodies, preparation of extracts and Western blotting.
The mouse monoclonal antibody M73 against Ad5-E1A exon 2 was a kind gift of E. Harlow (Massachusetts General Hospital Cancer Centre, Charlestown, MA, USA) (Harlow et al., 1985) . The polyclonal rabbit antibody against p21 CIP"/WAF" (C19), the rabbit polyclonal antibody against p16 INK%A (H-156), the rabbit polyclonal antibody against cyclin A (H-432) and the mouse monoclonal antibody against PCNA (PC10) were purchased from Santa Cruz. Anti-cdk2 (rabbit polyclonal antiserum) was described before (Kranenburg et al., 1995) .
For the determination of protein levels, extracts were prepared as follows : exponentially growing cells were washed twice with PBS and incubated for 30 min at 4 mC in a buffer consisting of 50 mM HEPES pH 7n4, 250 mM NaCl, 0n5 % NP-40, 50 mM NaF and 10 mM Na $ VO % supplemented with PMSF, trypsin inhibitor, leupeptin, pepstatin and aprotinin as protease inhibitors. Subsequently, the lysate was centrifuged for 10 min at 4 mC and the supernatants were used for further analysis. For the analysis of protein-protein interactions, extracts were prepared as described above, with the exception that a different buffer was used (binding buffer : 50 mM Tris pH 8, 250 mM NaCl, 5 mM EDTA, 0n1% NP-40, 50 mM NaF, 10 mM Na $ VO % supplemented with protease inhibitors). Protein concentrations were measured with the Bio-Rad protein assay kit. Western blotting was essentially performed as recommended by Santa Cruz, on Immobilon P membranes (Millipore). For detection, ECL reagent was used (Amersham).
In vitro translation. The p21 CIP"/WAF" protein was synthesized using two different methods. Firstly, for the experiment shown in Fig.  4 (B), a PCR reaction was performed on plasmid pCEP4-WAF1 with an oligonucleotide containing the T7 promoter sequence followed by a Kozak sequence as the forward primer (Roest et al., 1993) . The p21 CIP"/WAF" protein was subsequently synthesized in vitro with the TT-coupled transcription-translation system as recommended by the manufacturer (Promega), with the PCR fragment as a template. Secondly, for the experiment shown in Fig. 4 (C), pCMX-p21 and pCMX-p27 were in vitro transcribed and translated with the same TT-coupled transcription-translation system.
GST ' pull-down ' experiments.
The following GST-E1A fusion proteins were used : GST-5E1A, GST-5E1A-N-CR1, GST-5E1A-exon 1 (N-CR1-CR2), GST-5E1A-exon 2 (J. C. Dorsman, unpublished) . Ex-pression plasmids encoding GST-p21(1-164), and were a generous gift of R. Fotedar (Institut de Biologie Structurale, Grenoble, France) (Fotedar et al., 1996) .
For the GST-E1A ' pull-down ' experiments, equal amounts of GST alone and GST-5E1A fusion proteins were bound to glutathioneSepharose beads which were subsequently incubated with in vitro translated, [$&S]methionine-labelled p21 CIP"/WAF" or p27 KIP" in 400 µl binding buffer. After 3-4 h of incubation, the beads were centrifuged and washed, and GST or GST fusion proteins with associating proteins were resolved on a 12n6 % SDS-polyacrylamide gel. Associated p21 CIP"/WAF" and p27 KIP" were visualized by autoradiography after treatment of the gels with PPO-DMSO. As input 15 % of the total amount that was used in the GST ' pull-down ' experiments, was loaded.
For the GST-p21 ' pull-down ' experiments essentially the same procedure as described above was used with the following exceptions. The GST proteins were mixed with 900 µg cell extract from E1A-expressing NRK-Xho cells. Bound E1A was visualized in a Western procedure with monoclonal antibody M73 against E1A as first antibody. As input 10 µg whole cell extract was loaded. In the experiment shown in Fig. 4 (E) smaller amounts of GST-p21 than of the other GST fusion proteins were used since it was more difficult to obtain high expression levels of GST-p21 in bacteria.
The possibility of a direct interaction between E1A and p21 CIP"/WAF" was analysed in ' pull-down ' experiments with purified GST-p21 and purified baculovirus-derived His-E1A. Purified His-E1A was obtained as follows : a recombinant baculovirus expressing Ad5-12S E1A with six histidine residues linked to the N terminus (His-E1A) was constructed according to a previously described procedure (Peeper et al., 1992) . Sf9 cells were infected with virus and after 42 h cell extracts were prepared and His-E1A was purified on an Ni# + -NTA-agarose column (Qiagen) according to the manufacturer's recommended protocol. As input 10 % of the total amount that was used in the GST ' pull-down ' experiments was loaded.
Fluorescence-activated cell sorting (FACS) analysis. U2OS cells were plated on a 9 cm dish and transfected with 10 µg pCMX, 1 µg pCMX-p21 and 9 µg pCMX, 3 µg pCMX-p21 and 7 µg pCMX, or 10 µg pCMX-p21, in the presence of either 30 µg pRSV-5E1A or 30 µg pRSVneo and in the presence of 3 µg pCMV-CD20. In parallel, the same experiments were performed with pCMV-p16. After 24 h the precipitate was removed, medium supplemented with 50 ng\ml nocodazole was added and the cells were incubated for 16 h. The cells were subsequently washed with PBS, removed from the dish by treatment with trypsin, and washed with PBS supplemented with 20 mM HEPES pH 7n6 and 0n1% BSA. After centrifugation, the cells were incubated in a 20 ml CD20-FITC solution (Pharmingen) for 1 h. Cells were subsequently washed with PBS and fixed in 75 % ethanol in PBS for at least 30 min. After removal of the ethanol, cells were resuspended in PBS containing 0n2 mg\ml RNaseA and 0n01 mg\ml propidium iodide. The samples were analysed with a Becton-Dickinson FACS scan with LYSIS II software. In parallel, cells in 6 cm dishes were transfected with the same precipitate ; nocodazole was again added after 24 h, and 16 h later lysates were prepared in Laemmli sample buffer (Harlow & Lane, 1988) . These lysates were analysed for expression of the transfected genes in Western blot experiments.
Results

p21 CIP1/WAF1 is expressed in Ad5E1-transformed cells and still functions as a growth inhibitor
The cdk-inhibitor p21 CIP"/WAF" is a negative regulator of progression through the cell cycle. Since this regulation in Ad5E1-transformed cells is severely disturbed, we examined whether the levels of expression and\or functions of this inhibitor are influenced by the Ad transforming proteins. Firstly, various human and rat Ad5E1-transformed cell lines were tested for p21 CIP"/WAF" expression levels (see Fig. 1 ). In two independent Ad5E1-transformed human cell lines, HERXho c1 and c2, the levels of p21 CIP"/WAF" were higher than in the primary cells (see Fig. 1 , lanes 2 and 3 vs lane 1), whereas in two transformed rat cell lines, NRK-Xho c2.1 and c2.4, expression was slightly lower than in the untransformed NRK cells (see Fig. 1 , lanes 5 and 6 vs lane 4). Apparently, p21 CIP"/WAF" is still expressed in Ad5E1-transformed cells and expression is, in general, not downregulated.
To determine whether the growth-inhibitory pathway of p21 CIP"/WAF" is still intact in Ad5E1-transformed cells, we tested whether overexpression of p21 CIP"/WAF" is able to inhibit the growth of these cells. To this end, we performed a colony-formation assay in which Ad5E1-transformed BRKXho c22 cells, Ad5E1-transformed HER-Xho c1 cells or untransformed NRK cells were transfected with equal amounts of pCMV-p21, pCMV-p16 or a control vector (pCMV-neo). The cell lines chosen for this study can all be transfected with good efficiencies with the calcium phosphate method. After 3 weeks of selection with G418-containing medium, neomycinresistant colonies were counted and relative percentages of colony formation were calculated. Fig. 2 shows that, as expected, overexpression of either p21 CIP"/WAF" or p16 INK%A in untransformed NRK cells suppresses colony formation. In Ad5E1-transformed cells, overexpression of p21 CIP"/WAF" still negatively affects the outgrowth of colonies, although slightly less efficient than in untransformed cells (see Fig. 2 ). These results indicate that, in principle, p21 CIP"/WAF" and its downstream targets can still function in these cells. In contrast, no inhibition of colony formation is seen in Ad5E1-transformed cells, when p16 INK%A is overexpressed (see also Fig. 2 ). These results are as expected, since previous studies showed that p16 INK%A functions as a growth inhibitor only in cells with active pRb (Lukas et al., 1995 ; Medema et al., 1995) and in Ad5E1-transformed cells pRb is inactivated by binding to E1A (Nevins, 1992) . In the BRK-Xho cells, there was even an increase in the number of colonies, when p16 INK%A is overexpressed.
Ad5-E1A can partially overcome a p21 CIP1/WAF1 -induced G1 arrest
Since the colony-formation assays suggest that the Ad5E1 region may be able to partially relieve growth repression mediated by p21 CIP"/WAF" , we investigated whether a p21 CIP"/WAF" -induced G1 arrest could be (partially) relieved by E1A. To this end, we performed FACS analysis of U2OS cells transfected with increasing amounts of either pCMV-p21 or pCMV-p16 together with either pRSV-5E1A or a control vector. All cells were co-transfected with a CD20-expressing plasmid to analyse the transfected cells afterwards. Cells were also stained with propidium iodide to determine the DNA content. For an accurate determination of the number of cells arrested in the G1 phase we added nocodazole, which arrests cells in the G2\M phase (Zieve et al., 1980) . Accordingly, cells that have not already been arrested in the G1 phase by the overexpression of the inhibitory proteins, will arrest in the G2\M phase. In Fig. 3 (B) , the percentages of cells in the G1 phase are shown compared with cells transfected with the control vectors. Increasing amounts of pCMV-p21 or pCMVp16 induce a G1 arrest which is reflected by increasing percentages of cells in G1 phase (Fig. 3) . In this experiment, lower amounts of pCMV-p16 than of pCMV-p21 already gave rise to a maximal G1 arrest. As expected for cells in which pRb is inactivated, p16 INK%A does not function as a growth inhibitor when co-expressed with E1A ( Fig. 3 and Lukas et al., 1995 ; Medema et al., 1995) . However, increasing amounts of pCMV-p21 still give rise to an increase in G1-phase cells in the presence of pRSV-5E1A. This result is in agreement with the colony-formation assay (see Fig. 2 ) in which overexpressed p21 CIP"/WAF" retained the capacity to function as a growth inhibitor in the presence of E1A. However, E1A can overcome the growth-inhibitory properties of moderately overexpressed levels of p21 CIP"/WAF" and partially those of higher levels of p21 CIP"/WAF" , as can be seen in Fig. 3 : the increase in G1-phase cells observed with increasing pCMV-p21 concentrations is decreased in the presence of pRSV-5E1A. Essentially the same results were obtained with E1A and E1B together or without addition of nocodazole (data not shown). As a control, expression levels of the transfected proteins were tested by Western blot analysis. The levels of overexpressed p21 CIP"/WAF" and p16 INK%A are not affected by co-expression of E1A (data not shown). Together, these results suggest that E1A can partially abrogate the p21 CIP"/WAF" -induced G1 arrest. 
The transforming domains of the E1A proteins can bind to p21 CIP1/WAF1
Since E1A can partially overcome a p21 CIP"/WAF" -induced G1 arrest, we examined whether the observed inactivation of p21 CIP"/WAF" by E1A may be caused by binding. To this end, we performed GST ' pull-down ' experiments with various GST-5E1A fusion proteins and in vitro translated, [$&S]methionine-labelled p21 CIP"/WAF" . The composition of the GST fusion proteins is shown in Fig. 4 (A) . It is evident from Fig.  4 (B) that GST-5E1A binds to p21 CIP"/WAF" and that this association is specific since GST alone does not display binding to p21 CIP"/WAF" (Fig. 4 B, lane 2) . In addition, the same figure shows that the N-terminal domain and the CR1 region of E1A are sufficient for binding to p21 CIP"/WAF" , whereas no binding to the C-terminal domain of E1A encoded by exon 2 can be observed (see Fig. 4 B, lanes 3 and 5) . When GST ' pull-down ' experiments were performed with extracts prepared from NRK cells as a source for p21 CIP"/WAF" , essentially the same results were obtained (data not shown). Subsequently, we compared the efficiency of binding of p21 CIP"/WAF" to E1A with that of an already identified E1A-binding protein, the highly related cdk-inhibitor p27 KIP" (Mal et al., 1996 ; Nomura et al., 1998) . Fig. 4 (C) shows that the binding of p21 CIP"/WAF" to E1A is at least as efficient as the binding of p27 KIP" to E1A. Furthermore, binding experiments with purified GST-p21 and purified baculovirus-derived His-E1A suggest that the interaction is direct (Fig. 4 D) . All forms of E1A can bind equally well to the p21 CIP"/WAF" protein, as was visible on longer exposures (results not shown). Together the results indicate that p21 CIP"/WAF" has the capacity to bind directly to regions of E1A that are important for transformation (Moran & Mathews, 1987) .
The binding region of E1A on the p21 CIP"/WAF" protein was also determined. The p21 CIP"/WAF" cdk-inhibitor contains two separate domains, an N-terminal domain binding to cyclins and cyclin-dependent kinases and a C-terminal domain binding to PCNA (Luo et al., 1995) . To map the binding to the N-or C-terminal domain, GST-p21(1-164) encompassing the full-length protein, encompassing the Nterminal domain and GST-p21C(74-164) encompassing the Cterminal domain were incubated with extracts prepared from Ad5E1-transformed NRK cells. GST fusion proteins and associating proteins were isolated and Western blot analysis was performed with anti-E1A antibodies (see Fig. 4 E) . The results suggest that E1A binds primarily to the N terminus of p21 CIP"/WAF" (see Fig. 4 E, lane 4) , while almost no binding to the C-terminal half of p21 CIP"/WAF" can be observed (see Fig.  4 E, lane 3) . As a control, the same Western blot was also probed with antibodies against the already identified p21 CIP"/WAF" -binding proteins cdk2 and PCNA (Luo et al., 1995) . In the case of cdk2, only GST-p21(1-164) and containing the N terminus of p21 CIP"/WAF" showed association, as expected, whereas in the case of PCNA only fusion proteins containing the C terminus of p21 CIP"/WAF" exhibited binding (data not shown). 
Discussion
In Ad5E1-transformed cells the normal regulation of progression through the cell cycle is disturbed due to interference with the functions of important cellular regulatory proteins. The E1A oncoproteins affect the function of several cell-cycle-regulatory proteins via direct associations which can lead to the altered expression of other cellular genes (reviewed in Peeper & Zantema, 1993 ; Moran, 1994) . Since the cdkinhibitor p21 CIP"/WAF" , like its family members p27 KIP" and p57 KIP# , is a potent growth inhibitor, it seems likely that inhibition by E1A of its level and\or function may stimulate cell growth and transformation. In the present study, we therefore have analysed the interplay between E1A and this inhibitor.
The expression levels of p21 CIP"/WAF" were rather high and, in general, not downregulated in the Ad5E1-transformed cells used in this study. In two independent human HER-Xho cell lines higher levels and in two independent rat NRK-Xho cell lines slightly lower levels of p21 CIP"/WAF" were detected compared to untransformed cells. It had been reported previously that in transformed cells p21 CIP"/WAF" is released from cyclin A\cdk2 complexes (Xiong et al., 1993) . In the Ad5E1-transformed cells used in this study, however, complexes consisting of cyclin A\cdk2\p21 CIP"/WAF" could still be detected. Significantly, no p21 CIP"/WAF" -associated kinase activity was detected whereas antibodies raised against cyclin A can efficiently precipitate kinase activities (data not shown). These results indicate that p21 CIP"/WAF" is in principle still capable of functioning as a cdk inhibitor in Ad-transformed cells. In agreement with this observation, overexpressed p21 CIP"/WAF" can still negatively affect cell growth in Ad5E1-transformed cells. Firstly, overexpression of p21 CIP"/WAF" in Ad5E1-transformed cells leads to a reduction in the number of colonies in a colony-formation assay. Secondly, FACS analysis showed that increased amounts of pCMV-p21 can still give rise to an increase in G1-phase cells in the presence of pRSV-5E1A. These results indicate that p21 CIP"/WAF" and its downstream targets are, in principle, still able to function in Ad5E1-transformed cells.
However, in the presence of E1A, the growth inhibition induced by p21 CIP"/WAF" is less pronounced, as was observed in both the colony-formation assays and, more clearly, in the FACS experiments. Consequently, E1A can counteract the growth-inhibitory effect of p21 CIP"/WAF" at moderate concentrations of p21 CIP"/WAF" . A possible cause for this counteractive effect of E1A could be an increase in the levels of cyclin A, which is a growth-stimulatory protein (Buchou et al., 1993 ;  1, input). Associated His-E1A was detected with mouse monoclonal antibody M73 in a Western blot. (E) GST (lane 2), (lane 3), GST-p21N(1-103) (lane 4) and GST-p21(1-164) (lane 5) were mixed with cell extracts of Ad5E1-transformed NRK cells. Lane 1 contains whole cell extract (WCE). Bound E1A was detected with mouse monoclonal antibody M73 on a Western blot. Zerfass et al., 1996) . However, Western blots of cell extracts of the same transfected cells as used in the FACS analysis showed no significant increase in cyclin A levels (data not shown). Together, these data suggest that E1A is able to partially overcome the concentration-dependent p21 CIP"/WAF" -induced G1 arrest by acting directly on p21 CIP"/WAF" or dosedependently on a downstream target of p21 CIP"/WAF" . Similar results were obtained for p21 CIP"/WAF" and SV40 large T antigen, which can also act in a mutually antagonistic manner (Harper et al., 1993) .
In contrast to p21 CIP"/WAF" , the cdk-inhibitor p16 INK%A no longer shows a growth-inhibitory effect in Ad5E1-transformed cells at any concentration. These results are in agreement with the facts that cell-cycle inhibition by p16 INK%A is pRbdependent (Lukas et al., 1995 ; Medema et al., 1995) and that pRb is inactivated in Ad5E1-transformed cells by binding to E1A (Nevins, 1992) . In the Ad5E1-transformed BRK cell line, we even observed an increase in the number of colonies when p16 INK%A is overexpressed. However, this phenomenon is not observed in the HER-Xho cell line.
The best known mechanism by which E1A interferes directly with the function of cell-cycle-control proteins is by association. Therefore, we tested whether the partial relief by E1A of a p21 CIP"/WAF" -induced G1 arrest, which we observed in the FACS experiments, could be caused by the inactivation of p21 CIP"/WAF" via association to the E1A proteins. In vitro binding studies indeed showed specific binding of p21 CIP"/WAF" to E1A and that this binding is direct. Confirming previous studies (Mal et al., 1996 ; Nomura et al., 1998) we also detected binding of E1A to the related cdk-inhibitor p27 KIP" , but the observed interaction was slightly less efficient as that observed for p21 CIP"/WAF" . The regions of E1A that bind to p21 CIP"/WAF" are the non-conserved N-terminal region and the CR1 region. Both these E1A domains are required for transformation and can bind to and inactivate a number of regulatory proteins (Peeper & Zantema, 1993 ; Moran, 1994) . Hence, the observed binding of p21 CIP"/WAF" to this region of E1A could be functionally relevant and important for the transformation process.
The binding site of E1A on p21 CIP"/WAF was also determined. We found that E1A predominantly binds to the Nterminal half of p21 CIP"/WAF" , in which the cyclin\cdk-binding domain is located (Luo et al., 1995) . This is the region of p21 CIP"/WAF" which displays a clear homology with the Nterminal region of the cdk-inhibitor p27 KIP" (Toyoshima & Hunter, 1994) . The mapping of the domain in p27 KIP" involved in binding to E1A, however, led to different conclusions on the importance of the N-terminal region (Mal et al., 1996 ; Nomura et al., 1998) . The fact that in those studies different fragments representing the N-terminal regions have been used may be relevant for this discrepancy. Nomura et al. (1998) used constructs which are comparable to our constructs and, consistent with our results, binding to the conserved Nterminal domain of p27 KIP" was observed. Together these data suggest that E1A can interfere with functions of p21 CIP"/WAF" and p27 KIP" by similar mechanisms and thereby prevent p21 CIP"/WAF" and p27 KIP" from inducing a cell-cycle arrest.
Recently, various groups have reported on binding studies between p21 CIP"/WAF" and an oncoprotein which displays similarities to E1A, the papillomavirus E7 protein. In differentiated keratinocytes or after DNA damage, an in vivo interaction of p21 CIP"/WAF" and E7 could be observed Funk et al., 1997) . In contrast to E1A, which primarily binds the N terminus of p21 CIP"/WAF" , E7 can bind the C terminus of this inhibitory protein (Funk et al., 1997) . However, cases have also been reported in which no binding of p21 CIP"/WAF" to E7 could be detected (Ruesch & Laimins, 1997 ; Morozov et al., 1997 ; . In fact, we were unable to detect a significant amount of binding of p21 CIP"/WAF" to E1A in vivo in normally growing Ad5E1-transformed human HER-Xho cells, although in some experiments a weak interaction could be observed (data not shown). Possibly, in exponentially growing cells only a small portion of the total amount of p21 CIP"/WAF" is bound to E1A or, alternatively, the binding is rather weak and therefore difficult to detect. It remains possible, however, that binding has an effect on p21 CIP"/WAF" function. Since p21 CIP"/WAF" , and also p27 KIP" , are thought to maintain a certain threshold in the cell needed to be overcome by cyclin-dependent kinases before progression through the cell cycle can take place (reviewed by Nasmyth & Hunt, 1993 ; Peters, 1994) , a decrease of this critical level for cell-cycle progression through inactivation of at least a part of the total amount of functional p21 CIP"/WAF" and possibly p27 KIP" might provide a growth advantage. This may be one of the mechanisms by which E1A promotes cell growth. Moreover, as also holds for the related E7 protein, binding of E1A to p21 CIP"/WAF" may be more prominent in certain cell situations than under other cell conditions. In summary, it is evident that viral proteins such as E1A, E7 and SV40 large T may use various strategies to promote cellular growth by influencing the expression levels and\or functions of important cell-cycle-control proteins (reviewed in Jansen- Du$ rr, 1996) . The finding that E1A, E7 and SV40 large T all interfere with p21 CIP"/WAF" function suggests that inhibition of this cdk inhibitor may play an important role in transformation and oncogenesis, possibly by diminishing the threshold for cell-cycle progression.
